An increasing number of factors thwart efforts to bring new technologies to patients suffering from cardiovascular disease. In the minds of physician researchers and industry leaders, regulatory barriers, less financial return on investment and government impediments interfere with innovation. However, if innovators can adapt and evolve to a more global healthcare ecosystem, a silver lining may materialize.